Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.
Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:
(12) Patent Application: | (11) CA 2414352 |
---|---|
(54) English Title: | METHOD OF TREATING PERIPHERAL VASCULAR DISEASES, PERIPHERAL NEUROPATHIES, AND AUTONOMIC NEUROPATHIES |
(54) French Title: | TRAITEMENT DES MALADIES VASCULAIRES PERIPHERIQUES, DES NEUROPATHIES DU SYSTEME NERVEUX PERIPHERIQUES ET DES NEUROPATHIES DU SYSTEME NERVEUX AUTONOME |
Status: | Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication |
(51) International Patent Classification (IPC): |
|
---|---|
(72) Inventors : |
|
(73) Owners : |
|
(71) Applicants : |
|
(74) Agent: | SMART & BIGGAR LP |
(74) Associate agent: | |
(45) Issued: | |
(86) PCT Filing Date: | 2001-06-29 |
(87) Open to Public Inspection: | 2002-01-10 |
Examination requested: | 2002-12-24 |
Availability of licence: | N/A |
Dedicated to the Public: | N/A |
(25) Language of filing: | English |
Patent Cooperation Treaty (PCT): | Yes |
---|---|
(86) PCT Filing Number: | PCT/US2001/041202 |
(87) International Publication Number: | US2001041202 |
(85) National Entry: | 2002-12-24 |
(30) Application Priority Data: | |||||||||
---|---|---|---|---|---|---|---|---|---|
|
A method of treating a patient suffering from peripheral vascular disease,
peripheral neuropathies, or autonomic neuropathies by administering a cGMP
PDE5 inhibitor such as sildenafil. The method is particularly applicable to
patients suffering from diabetic foot ulcers, Raynaud's Phenomenon, CREST
Syndrome, erythromatosis, rheumatoid diseases, diabetic retinopathies and
onychiomycosis. According to the present invention, a cGMP PDE5 inhibitor may
be administered as a prophylactic to patients predisposed to develop a
peripheral vascular disease, peripheral neuropathy or autonomic neuropathy.
L'invention concerne une méthode de traitement destinée à un patient souffrant d'une maladie vasculaire périphérique, de neuropathies du système nerveux périphérique ou de neuropathies du système nerveux autonome, comprenant l'administration d'un inhibiteur de cGMP PDE5 tel que le sildenafil. Cette méthode convient particulièrement pour les patients souffrant d'un ulcère diabétique du pied, d'un syndrome de Raynaud, d'un syndrome Crest, d'une érythromatose, de maladies rhumatoïdes, de rétinopathies diabétiques et d'onychomycoses. L'invention concerne également l'administration d'un inhibiteur de cGMP PDE5 en tant qu'agent de prévention à des patients présentant une prédisposition à une maladie vasculaire périphérique, une neuropathie périphérique ou une neuropathie du système nerveux autonome.
Note: Claims are shown in the official language in which they were submitted.
Note: Descriptions are shown in the official language in which they were submitted.
Sorry, the representative drawing for patent document number 2414352 was not found.
2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.
Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.
For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee and Payment History should be consulted.
Description | Date |
---|---|
Application Not Reinstated by Deadline | 2007-06-29 |
Time Limit for Reversal Expired | 2007-06-29 |
Inactive: Abandoned - No reply to s.30(2) Rules requisition | 2006-09-27 |
Inactive: Abandoned - No reply to s.29 Rules requisition | 2006-09-27 |
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice | 2006-06-29 |
Inactive: S.29 Rules - Examiner requisition | 2006-03-27 |
Inactive: S.30(2) Rules - Examiner requisition | 2006-03-27 |
Inactive: Cover page published | 2003-03-04 |
Inactive: First IPC assigned | 2003-03-02 |
Letter Sent | 2003-02-28 |
Letter Sent | 2003-02-28 |
Inactive: Acknowledgment of national entry - RFE | 2003-02-28 |
Application Received - PCT | 2003-01-31 |
National Entry Requirements Determined Compliant | 2002-12-24 |
Request for Examination Requirements Determined Compliant | 2002-12-24 |
All Requirements for Examination Determined Compliant | 2002-12-24 |
Application Published (Open to Public Inspection) | 2002-01-10 |
Abandonment Date | Reason | Reinstatement Date |
---|---|---|
2006-06-29 |
The last payment was received on 2005-03-14
Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following
Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO
Patent Fees
web page to see all current fee amounts.
Fee Type | Anniversary Year | Due Date | Paid Date |
---|---|---|---|
Basic national fee - standard | 2002-12-24 | ||
MF (application, 2nd anniv.) - standard | 02 | 2003-06-30 | 2002-12-24 |
Request for examination - standard | 2002-12-24 | ||
Registration of a document | 2002-12-24 | ||
MF (application, 3rd anniv.) - standard | 03 | 2004-06-29 | 2004-02-24 |
MF (application, 4th anniv.) - standard | 04 | 2005-06-29 | 2005-03-14 |
Note: Records showing the ownership history in alphabetical order.
Current Owners on Record |
---|
PFIZER INC. |
Past Owners on Record |
---|
RALPH E. WOOD |